Literature DB >> 17448730

Infection and the role of inflammation in preterm premature rupture of the membranes.

Ramkumar Menon1, Stephen J Fortunato.   

Abstract

Spontaneous preterm birth, caused by preterm labor (contractions before 37 weeks' gestation) or preterm premature rupture of the membranes (pPROM) (membrane rupture before the onset of labor) or both account for approximately 80% of preterm deliveries. pPROM is associated with 30-40% of preterm deliveries and the incidence of pPROM has increased in the past decade. The question we address here is why some women experience pPROM and some experience preterm labor with no rupture of membranes (ROM) when the etiologic factors associated with both these pathologic complications are the same. To date, studies had evaluated the markers that are commonly elevated in both preterm labor and pPROM. A better understanding of the similarities and differences between the biomolecular pathways leading to each of these conditions may open new avenues for research and intervention. In this chapter we review the role of inflammatory mediators (cytokines and matrix metalloproteinases), and programmed cell death (apoptosis) in preterm labor with no ROM and preterm labor with pPROM to delineate the differences in pathways between the two conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448730     DOI: 10.1016/j.bpobgyn.2007.01.008

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  57 in total

1.  Systemic inflammatory responses in progressing periodontitis during pregnancy in a baboon model.

Authors:  J L Ebersole; M J Steffen; S C Holt; L Kesavalu; L Chu; D Cappelli
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

2.  The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes.

Authors:  Seung Mi Lee; Roberto Romero; Jeong Woo Park; Sun Min Kim; Chan-Wook Park; Steven J Korzeniewski; Tinnakorn Chaiworapongsa; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-25

3.  Patterns of cytokine profiles differ with pregnancy outcome and ethnicity.

Authors:  Digna R Velez; Stephen J Fortunato; Nicole Morgan; Todd L Edwards; Salvatore J Lombardi; Scott M Williams; Ramkumar Menon
Journal:  Hum Reprod       Date:  2008-05-16       Impact factor: 6.918

4.  A high concentration of fetal fibronectin in cervical secretions increases the risk of intra-amniotic infection and inflammation in patients with preterm labor and intact membranes.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; Jihyun Kang; Joon-Seok Hong; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

Review 5.  Preterm prelabor rupture of the membranes: A disease of the fetal membranes.

Authors:  Ramkumar Menon; Lauren S Richardson
Journal:  Semin Perinatol       Date:  2017-08-12       Impact factor: 3.300

Review 6.  Preterm labor: one syndrome, many causes.

Authors:  Roberto Romero; Sudhansu K Dey; Susan J Fisher
Journal:  Science       Date:  2014-08-14       Impact factor: 47.728

Review 7.  Synergy and interactions among biological pathways leading to preterm premature rupture of membranes.

Authors:  Sophia M R Lannon; Jeroen P Vanderhoeven; David A Eschenbach; Michael G Gravett; Kristina M Adams Waldorf
Journal:  Reprod Sci       Date:  2014-05-19       Impact factor: 3.060

8.  Periodontitis in pregnant baboons: systemic inflammation and adaptive immune responses and pregnancy outcomes in a baboon model.

Authors:  J L Ebersole; S C Holt; D Cappelli
Journal:  J Periodontal Res       Date:  2013-05-28       Impact factor: 4.419

Review 9.  p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.

Authors:  Ramkumar Menon; John Papaconstantinou
Journal:  Expert Opin Ther Targets       Date:  2016-08-04       Impact factor: 6.902

10.  Human amnion mesenchymal cells are pro-inflammatory when activated by the Toll-like receptor 2/6 ligand, macrophage-activating lipoprotein-2.

Authors:  Brittany L Sato; Eric S Collier; Sheryl Anne Vermudez; Anthony D Junker; Claire E Kendal-Wright
Journal:  Placenta       Date:  2016-06-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.